TP53 and breast carcinoma: Dysregulation of the expression of individual annexins has been associated with breast cancer development and poor prognosis, and modulation of calcium signaling by p53 has been associated with lack of sensitivity to chemotherapy and radiotherapy [20, 22, 27, 45–49].